Company / Current Assets per Share
Akebia Therapeutics, Inc. Current Assets per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.12
FY2025
5-year range
$0.59 / $1.84
FY2021-FY2025
Trend
+92.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $1.12.
Based on SEC 10-K filings.
1.12 in FY2025 with a 10-year CAGR of -16.6%.
Improved from $0.64 to $1.12 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +2.4%
- 5-Year CAGR
- -18.1%
- 10-Year CAGR
- -16.6%
Key checks
Key Insights
- In FY2025, current assets per share increased 92.3% year-over-year.
- Peak current assets per share was recorded in FY2014.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.12 | +92.3% |
| FY2024 | $0.59 | -8.8% |
| FY2023 | $0.64 | -38.7% |
| FY2022 | $1.05 | -43.0% |
| FY2021 | $1.84 | -39.8% |
| FY2020 | $3.05 | +15.3% |
| FY2019 | $2.65 | -73.1% |
| FY2018 | $9.84 | +42.1% |
| FY2015 | $6.92 | -91.3% |
| FY2014 | $79.86 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026